Detalhe da pesquisa
1.
The clinical relevance of WDFY4 in autoimmune diseases in diverse ancestral populations.
Rheumatology (Oxford)
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507703
2.
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study.
Rheumatology (Oxford)
; 63(3): 657-664, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37228012
3.
Characteristics and risk factors of COVID-19 breakthrough infections in Idiopathic Inflammatory Myopathies: Results from the COVAD study.
Rheumatology (Oxford)
; 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430474
4.
Collaborative research in myositis-related disorders: MIHRA, a global shared community model.
Clin Exp Rheumatol
; 42(2): 207-212, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436382
5.
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.
Rheumatol Int
; 44(5): 805-817, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470502
6.
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey.
Rheumatol Int
; 44(1): 89-97, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668836
7.
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies.
Rheumatol Int
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609655
8.
Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies.
Ann Rheum Dis
; 82(2): 235-245, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171069
9.
Chimeric antigen receptor T-Cell therapy: a new emerging landscape in autoimmune rheumatic diseases.
Rheumatology (Oxford)
; 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37982747
10.
Non-trough serum drug levels of adalimumab and etanercept are associated with response in patients with psoriatic arthritis.
Rheumatology (Oxford)
; 2023 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070158
11.
Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohort.
Rheumatology (Oxford)
; 62(8): 2673-2682, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534822
12.
Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study.
Rheumatology (Oxford)
; 62(4): 1711-1715, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250907
13.
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis.
Rheumatology (Oxford)
; 62(7): 2366-2376, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315075
14.
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles.
Rheumatology (Oxford)
; 62(11): 3672-3679, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929923
15.
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.
Rheumatology (Oxford)
; 62(7): 2453-2463, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413073
16.
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey.
Rheumatology (Oxford)
; 62(3): 1204-1215, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35920795
17.
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: Results from the MYONET registry.
Rheumatology (Oxford)
; 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698987
18.
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys.
Rheumatology (Oxford)
; 62(12): 3838-3848, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36961331
19.
The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study.
Br J Dermatol
; 188(4): 542-551, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695406
20.
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study.
Clin Exp Rheumatol
; 41(2): 285-290, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861742